At 2.30pm, London’s AIM Index sat just over four points lower at 723.89, probing lows not seen since the immediate aftermath of the first wave of COVID more than three years ago.
- Vast Resources +65%
- Bradda Head +29%
- Anglo Asian Mining +11%
- N4Pharma -30%
- Shield Therapeutics -24%
Vast Resources LON:VAST was leading the pack at our 2.30pm copy time today, some 65% higher. The company provided an update on its Batia Plai mine in Romania, noting that strike action it advised of last week has now been terminated. That more than recovers those recent losses but still leaves the stock well off highs seen earlier in the year.
Bradda Head LON:BHL sat 29% higher at copy time, following news of a significant lithium resource expansion at its Arizona project, upgrading forecasts by 30%. Management add that so far only a small fraction of the license area has been explored.
Anglo Asian LON:AAZ gets the notable mention, adding 11% in the wake of feedback on an environmental report which had been submitted to local regulators. The mood here seems generally positive, but volumes have been limited. More traction is necessary and the implementation cost of the regulator’s recommendations also needs to be accounted for.
- UK Stock Market News: GSK, DCC, Shield Therapeutics
- AIM Market Roundup: Staffline, Vast Resources, Orosur Mining
- AIM Market Roundup: Marechale, Oxford Biodynamics, SDX Energy
N4Pharma LON:N4P slipped 30% by 2.30pm, leaving it at the foot of the table. The company announced an acquisition this morning, funded by a subscription of new ordinary shares.
Shield Therapeutics LON:STX was in second to last place, down 24% as we write. Again the move is related to funding, with the company having issued £5m of stock at 8p per share, representing a 17.9% discount to last night’s closing price.
Apologies for the sporadic timing and content of this note over the last couple of weeks. I have been travelling on business, creating challenges both with connectivity and time zones. BAU should resume from Monday.
